Double or nothing on cancer immunotherapy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 23302931.
- Also identified by DOI 10.1038/nbt.2471 and PMC identifier 6352981.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Engineered T cells expressing two receptors distinguish malignant cells from healthy cells even in the absence of a tumor-specific antigen.
Medical subject headings
- Antigens
- Combinatorial Chemistry Techniques
- Neoplasms
- Signal Transduction
- T-Lymphocytes